BUZZ-Australia's Rhythm Biosciences at nearly 6-month high on multi-year supply agreement
Reuters
Feb 03
BUZZ-Australia's <a href="https://laohu8.com/S/RHYN.AU">Rhythm Biosciences</a> at nearly 6-month high on multi-year supply agreement
** Shares of Rhythm BiosciencesRHY.AX rise as much as 33.3% to A$0.20, their highest level since August 6, 2025
** The medical diagnostics tech firm secures a multi-year commercial supply agreement executed with U.S.-based Quansys Biosciences for ColoSTAT reagent kit manufacturing
** Agreement provides scalable manufacturing capacity to support ColoSTAT Access Program and commercial rollout, adds co
** About 1.5 million shares change hands, 2.3x the 30-day average
** YTD, stock up 37% year, including the day's move
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.